Formulation and Evaluation of Immediate Release Tablets of Zopiclone

Author:

Devi Gottemukkula Lakshmi1,Singh Rishika1,Prathyusha N.1,Akhila J.1,Devender B.1,Sri. S Ramya2

Affiliation:

1. Department of Pharmaceutics, Joginpally B. R Pharmacy College, Moinabad, Hyderabad, Telangana, India.

2. Department of Pharmaceutics, University College of Technology, Osmania University, Hyderabad, Telangana, India.

Abstract

The current study's objective is to directly compress a Zopiclone rapid release tablet and assess it. The superdisintegrants (crospovidone, croscarmellose sodium, fenugreek) were used to hasten drug release from tablets. The prepared tablets pre-compression, post-compression characteristics were scrutinised. The interactions between the medication excipients were investigated using FTIR. The research shows that direct compression F3 formulations had a faster drug release of 100.05% over a 45-minute period than other Zopiclone formulations, which had lower dissolving rates when utilising Crospovidone.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference11 articles.

1. Manish J, Sonam R, Amit K, Sanjay KS, Bhupendra SC. A Review On Immediate Release Drug Delivery System By Using Design Of Experiment. Journal of Drug Discovery and Therapeutics. 2013; 1 (12): 21-7.

2. Vaseeha Banu TS, Jaiswal VA, Mohammad SA. Formulation and Evaluation of Transdermal Patches of Decongestant Drug. Research Journal of Pharmaceutical Dosage Forms and Technology. 2022; 14(3): 195-8.

3. Dedhiya MG, Rastogi SK, Chhettry A. Lercanidipine Immediate Release Compositions. United States Patient Application. 2006; 134-212.

4. Patrik E, Barbro J. New Oral Immediate Release Dosage Form. United States Patient Application. 2006.

5. Kaur V, Mehara N. A Review on: Importance of Superdisintegrant on Immediate Release Tablets. International Journal of Research and Scientific Innovation. 2016; 3: 39-43.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3